High resolution detection and analysis of CpG dinucleotides methylation using MBD-Seq technology.

Area of Science:

• Epigenetics and Genomics
• Molecular Biology
• Bioinformatics

Background:

• Methyl-CpG binding domain protein sequencing (MBD-seq) is a key technique for genome-wide DNA methylation profiling.
• Optimal experimental conditions and robust data analysis methods for MBD-seq are not well-established, limiting its application.
• Accurate DNA methylation analysis is crucial for understanding gene regulation and disease mechanisms.

Purpose of the Study:

• To determine optimal experimental parameters for high-depth MBD-seq.
• To develop and validate a novel computational model for MBD-seq data analysis.
• To assess the accuracy and resolution of the developed method for CpG dinucleotide methylation detection.

Main Methods:

• Generated high-depth MBD-seq data from MCF-7 cells.
• Optimized salt concentrations (500 mM and 1000 mM) for MBD-seq elution.
• Developed and applied a bi-asymmetric-Laplace model (BALM) for data analysis.
• Validated results using clonal bisulfite sequencing.

Main Results:

• Optimal MBD-seq efficiency was achieved with approximately 100 million unique mapped tags.
• The bi-asymmetric-Laplace model (BALM) accurately detected methylation status at individual CpG dinucleotides.
• High resolution and specificity were demonstrated in the tested genomic regions.
• BALM analysis correlated well with clonal bisulfite sequencing validation.

Conclusions:

• The combination of optimized MBD-seq and BALM provides a low-cost, efficient, and high-resolution tool for DNA methylome investigation.
• This approach enhances the reliability and accuracy of DNA methylation pattern analysis.
• The developed method offers a valuable resource for epigenetic research and biomarker discovery.